In Transfusion-Dependent Thalassemia Children, Increased Iron
Overload is Associated with Lower Serum Alpha-Klotho, Which is
Strongly Associated with Lower Total and Ionized Calcium
Concentrations

Shatha   Rouf   Moustafa; Hussein   Kadhem   Al-Hakeim; Zainab   Hussein   Alhillawi; Michael      Maes

doi:10.2174/1566524022666220607163232

Abstract

Background: Patients with transfusion-dependent thalassemia (TDT) show disorders in calcium metabolism. The α-Klotho protein is predominantly expressed in tissues that are involved in calcium homeostasis, and lowered levels are associated with bone disease. The aim of the study is to examine the associations between low α-Klotho status and calcium metabolism in relation to iron status in children with TDT.

Methods: Calcium, α-Klotho, parathyroid hormone (PTH), calcyphosin, vitamin D3, phosphorous, fibroblast growth factor receptor 2 (FGFR2), as well as iron and erythron biomarkers were measured in 60 children with TDT and 30 healthy control children.

Results: A meaningful part of TDT patients showed lowered α-Klotho levels, and those children also showed low serum total and ionized calcium concentrations. TDT patients showed increased PTH, FGFR2, and calcyphosin and lowered vitamin D3 as compared with healthy children. The α-Klotho levels were significantly correlated with total and ionized calcium (positively) and with iron overload and transfusions biomarkers (inversely). Partial Least Squares path analysis showed that 40.1% of the variance in serum total calcium could be explained by the regression on α-Klotho, vitamin D3 (both positively), and calcyphosin (inversely) and that the effects of the latter are mediated by iron overload and the number of blood transfusions.

Conclusion: In conclusion, the iron overload in TDT and its consequences may induce lowered levels of α-Klotho which in turn may lead to lower calcium thereby explaining at least in part the effects of TDT on bone metabolism including spontaneous pathological fractures, osteoporosis, osteopenia, and skeletal deformities.

Keywords: Calcium, α-Klotho, inflammation, oxidative stress, antioxidants, biomarkers.

« Previous Next »

[1]
Wahidiyat PA, Sastroasmoro S, Fucharoen S, Setianingsih I, Putriasih SA. Applicability of a clinical scoring criteria for disease severity of ß-thalassemia/hemoglobin E in Indonesia. Med J Indones  2018; 27(1): 26-32.
 [http://dx.doi.org/10.13181/mji.v27i1.1779]

[2]
Viprakasit V, Ekwattanakit SJHOC. Clinical classification, screening and diagnosis for thalassemia. 2018; 32(2): 193-211.
 [http://dx.doi.org/10.1016/j.hoc.2017.11.006]

[3]
Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis  2010; 5(1): 11.
 [http://dx.doi.org/10.1186/1750-1172-5-11] [PMID:  20492708]

[4]
Cappellini MD. Current status in iron chelation in hemoglobinopathies. 2008; 8(7): 663-74.

[5]
Malik S, Syed S, Ahmed N. Complications in transfusion–dependent patients of ß-thalassemia major: A review. Pak J Med Sci  2009; 25(4): 678-82.

[6]
Hamed AA, Elguindy W, Elhenawy YI, Ibrahim RH. Early cardiac involvement and risk factors for the development of arrhythmia in patients with β-thalassemia major. J Pediatr Hematol Oncol  2016; 38(1): 5-11.
 [http://dx.doi.org/10.1097/MPH.0000000000000467] [PMID:  26583617]

[7]
Daher R, Manceau H, Karim Z. Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. Presse Med  2017; 46(12 Pt 2): e272-8.
 [http://dx.doi.org/10.1016/j.lpm.2017.10.006] [PMID:  29129410]

[8]
Dhawan P, Kanojia RK, Chandra J, Kumar A, Anand R, Gupta S. Wrist joint skeletal changes in children with transfusion-dependent thalassemia. J Pediatr Orthop  2020; 40(6): e473-8.
 [http://dx.doi.org/10.1097/BPO.0000000000001523] [PMID:  32501918]

[9]
Salama OS, Al-Tonbary YA, Shahin RA, Sharaf Eldeen OAJH. Unbalanced bone turnover in children with β-
thalassemia. 2006; 11(3): 197-202.
 [http://dx.doi.org/10.1080/10245330600702851]

[10]
Saboor M, Qudsia F, Qamar K, Moinuddin MJJHTD. Levels
of calcium, corrected calcium, alkaline phosphatase and
inorganic phosphorus in patients’ serum with β-thalassemia
major on subcutaneous deferoxamine. 2014; 2(130): 2.

[11]
Merchant R, Udani A, Puri V, D’cruz V, Patkar D, Karkera AJTIJoP. Evaluation of osteopathy in thalassemia by bone
mineral densitometry and biochemical indices. 2010; 77(9): 987-1.

[12]
Angelopoulos NG, Goula A, Rombopoulos G, et al. Hypoparathyroidism in transfusion-dependent patients with β-thalassemia. J Bone Miner Metab  2006; 24(2): 138-45.
 [http://dx.doi.org/10.1007/s00774-005-0660-1] [PMID:  16502121]

[13]
Pirinççioğlu AG, Akpolat V, Köksal O, Haspolat K, Söker M. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone  2011; 49(4): 819-23.
 [http://dx.doi.org/10.1016/j.bone.2011.07.014] [PMID:  21798385]

[14]
Fung EB, Aguilar C, Micaily I, Haines D, Lal A. Treatment of vitamin D deficiency in transfusion-dependent thalassemia. Am J Hematol  2011; 86(10): 871-3.
 [http://dx.doi.org/10.1002/ajh.22117] [PMID:  21818763]

[15]
Al-Hakeim HK, Ridha MAS, Muhammed ZH. Calcium status in severe iron overload Iraqi thalassemia major patients. Biochem Cell Arch  2018; 18: 22-32.

[16]
Aslan I, Canatan D, Balta N, et al. Bone mineral density in thalassemia major patients from Antalya. Int J Endocrinol 2012.
 [http://dx.doi.org/10.1155/2012/573298]

[17]
Voskaridou E, Christoulas D, Plata E, et al. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density. Horm Metab Res  2012; 44(12): 909-13.
 [http://dx.doi.org/10.1055/s-0032-1312618]

[18]
Angelopoulos NG, Goula A, Rombopoulos G, et al. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab  2006; 24(2): 138-45.
 [http://dx.doi.org/10.1007/s00774-005-0660-1] [PMID:  16502121]

[19]
Voskaridou E, Christoulas D, Xirakia C, et al. Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. Haematologica  2009; 94(5): 725-8.

[20]
Abd El-Moneim ES, Zolaly MA, Al-Hawsawi ZM, Abdelmoneim AA, Abosdera MM. Age-related changes in biochemical bone profile in thalassemic children. Pediatr Neonatol  2018; 59(2): 189-97.
 [http://dx.doi.org/10.1016/j.pedneo.2016.08.012] [PMID:  28967496]

[21]
Salah H, Atfy M, Fathy A, Atfy M, Mansor H, Saeed J. The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. Immunol Invest  2010; 39(8): 820-32.
 [http://dx.doi.org/10.3109/08820139.2010.498492] [PMID:  20718662]

[22]
Al-Hakeim HK, Alhillawi ZH. Effect of serum fibroblast growth factor receptor 2 and CAPS proteins on calcium status in β-thalassaemia major patients who are free from overt inflammation. Growth Factors  2018; 36(3-4): 178-85.
 [http://dx.doi.org/10.1080/08977194.2018.1520707] [PMID:  30375242]

[23]
Clément S, Dumont JE, Schurmans S. Loss of calcyphosine gene expression in mouse and other rodents. Biochem Biophys Res Commun  1997; 232(2): 407-13.
 [http://dx.doi.org/10.1006/bbrc.1997.6297] [PMID:  9125191]

[24]
Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development  2002; 129(16): 3783-93.
 [http://dx.doi.org/10.1242/dev.129.16.3783] [PMID:  12135917]

[25]
Katoh M. FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies. J Invest Dermatol  2009; 129(8): 1861-7.
 [http://dx.doi.org/10.1038/jid.2009.97] [PMID:  19387476]

[26]
Wilkie AO. Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev  2005; 16(2): 187-203.
 [http://dx.doi.org/10.1016/j.cytogfr.2005.03.001] [PMID:  15863034]

[27]
Stefanopoulos D, Nasiri-Ansari N, Dontas I, et al. Fibroblast Growth Factor 23 (FGF23) and klotho protein in beta-thalassemia. Horm Metab Res  2020; 52(3): 194-201.
 [http://dx.doi.org/10.1055/a-1104-5326] [PMID:  32215890]

[28]
Saghiv M. The klotho gene and soluble klotho in health and disease: From 1997-2018; A review. Ann cardiol. Vasc Med  2018; 2: 1007.

[29]
Lewin E, Olgaard K. Klotho, an important new factor for the activity of Ca2+ channels, connecting calcium homeostasis, ageing and uraemia. Nephrol Dial Transplant  2006; 21(7): 1770-2.
 [http://dx.doi.org/10.1093/ndt/gfl178] [PMID:  16627600]

[30]
Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature  1997; 390(6655): 45-51.
 [http://dx.doi.org/10.1038/36285] [PMID:  9363890]

[31]
Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature  2006; 444(7120): 770-4.
 [http://dx.doi.org/10.1038/nature05315]

[32]
Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease. Exp Cell Res  2012; 318(9): 1040-8.
 [http://dx.doi.org/10.1016/j.yexcr.2012.02.027] [PMID:  22421513]

[33]
Xu Y, Sun Z. Molecular basis of klotho: From gene to function in aging. Endocr Rev  2015; 36(2): 174-93.
 [http://dx.doi.org/10.1210/er.2013-1079] [PMID:  25695404]

[34]
Kuro-o M. Klotho. Pflugers Arch  2010; 459(2): 333-43.
 [http://dx.doi.org/10.1007/s00424-009-0722-7] [PMID:  19730882]

[35]
Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science  2005; 309(5742): 1829-33.
 [http://dx.doi.org/10.1126/science.1112766] [PMID:  16123266]

[36]
Yamamoto M, Clark JD, Pastor JV, et al. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem  2005; 280(45): 38029-34.
 [http://dx.doi.org/10.1074/jbc.M509039200] [PMID:  16186101]

[37]
Mateu-de Antonio J. New predictive equations for serum ionized calcium in hospitalized patients. Med Princ Pract  2016; 25(3): 219-26.
 [http://dx.doi.org/10.1159/000443145] [PMID:  26642197]

[38]
Elsayed ME, Sharif MU, Stack AG. Chapter four - Transferrin saturation: A body iron biomarker. Adv Clin Chem  2016; 75: 71-97.

[39]
Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B  1995; 57(1): 289-300.
 [http://dx.doi.org/10.1111/j.2517-6161.1995.tb02031.x]

[40]
Ringle C, Da Silva D, Bido D. Structural equation modeling with the SmartPLS. Bido, D, da Silva, D, & Ringle, C(2014) Structural Equation Modeling with the Smartpls. Brazilian J Mark  2015; 13(2): 18.

[41]
Al-Hakeim HK, Najm AH, Al-Dujaili AH, Maes M. Major depression in children with transfusion-dependent thalassemia is strongly associated with the combined effects of blood transfusion rate, iron overload, and increased pro-inflammatory cytokines. Neurotox Res  2020; 38(1): 228-41.
 [http://dx.doi.org/10.1007/s12640-020-00193-1] [PMID:  32335809]

[42]
Xu Y, Peng H, Ke B. α-klotho and anemia in patients with
chronic kidney disease patients: A new perspective. Exp Ther Med  2017; 14(6): 5691-5.
 [http://dx.doi.org/10.3892/etm.2017.5287] [PMID:  29250136]

[43]
Saito K, Ishizaka N, Mitani H, Ohno M, Nagai R. Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett  2003; 551(1-3): 58-62.
 [http://dx.doi.org/10.1016/S0014-5793(03)00894-9] [PMID:  12965205]

[44]
Al-Hakeim HK, Auda FM, Ali BM. Lack of correlation between non-labile iron parameters, total carbonyl and malondialdehyde in major thalassemia. J Clin Biochem Nutr  2014; 55(3): 203-6.
 [http://dx.doi.org/10.3164/jcbn.14-24] [PMID:  25411527]

[45]
Su XM, Yang W. α-Klotho is an acute phase protein and
altered by restraint stress in mice. Int J Clin Exp Pathol  2014; 7(9): 5922-6.
 [PMID:  25337236]

[46]
Ravikumar P, Ye J, Zhang J, et al. α-Klotho protects against
oxidative damage in pulmonary epithelia. Am J Physiol Lung Cell Mol Physiol  2014; 307(7): L566-75.
 [http://dx.doi.org/10.1152/ajplung.00306.2013] [PMID:  25063799]

[47]
Sun S, Cheng B, Sun PG, Wu XH, Wu QQ, He P. RTEF-1 protects against oxidative damage induced by H2O2 in human umbilical vein endothelial cells through klotho activation. Exp Biol Med  2015; 240(12): 1606-13.
 [http://dx.doi.org/10.1177/1535370215587914] [PMID:  26041389]

[48]
Wang Y, Kuro-o M, Sun Z. Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway. Aging Cell  2012; 11(3): 410-7.
 [http://dx.doi.org/10.1111/j.1474-9726.2012.00796.x] [PMID:  22260450]

[49]
Izbeki F, Asuzu DT, Lorincz A, et al. Loss of Kitlow progenitors, reduced stem cell factor and high oxidative stress underlie gastric dysfunction in progeric mice. J Physiol  2010; 588(Pt 16): 3101-17.
 [http://dx.doi.org/10.1113/jphysiol.2010.191023] [PMID:  20581042]

[50]
Vadakke Madathil S, Coe LM, Casu C, Sitara D. Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis. Am J Pathol  2014; 184(3): 827-41.
 [http://dx.doi.org/10.1016/j.ajpath.2013.11.016] [PMID:  24412515]

[51]
Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem  2008; 389(3): 233-41.
 [http://dx.doi.org/10.1515/BC.2008.028] [PMID:  18177265]

[52]
Hosokawa K, Arai F, Yoshihara H, et al. Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction. Biochem Biophys Res Commun  2007; 363(3): 578-83.
 [http://dx.doi.org/10.1016/j.bbrc.2007.09.014] [PMID:  17897629]

[53]
Baldan A, Giusti A, Bosi C, et al. Klotho, a new marker for osteoporosis and muscle strength in β-thalassemia major. Blood Cells Mol Dis  2015; 55(4): 396-401.
 [http://dx.doi.org/10.1016/j.bcmd.2015.08.004] [PMID:  26460265]

[54]
Nabeshima Y, Imura H. α-Klotho: A regulator that integrates
calcium homeostasis. Am J Nephrol  2008; 28(3): 455-64.
 [http://dx.doi.org/10.1159/000112824] [PMID:  18160815]

[55]
Nabeshima Y. Discovery of α-Klotho unveiled new insights into calcium and phosphate homeostasis. Proc Jpn Acad, Ser B, Phys Biol Sci  2009; 85(3): 125-41.
 [http://dx.doi.org/10.2183/pjab.85.125] [PMID:  19282648]

[56]
Nabeshima Y. The discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis. Cell Mol Life Sci  2008; 65(20): 3218-30.
 [http://dx.doi.org/10.1007/s00018-008-8177-0] [PMID:  18726073]

[57]
Nijenhuis T. TRPV5 and TRPV6 in Ca. 2005; 2: 181-92.

[58]
Lu P, Boros S, Chang Q, Bindels RJ, Hoenderop JG. The β-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant  2008; 23(11): 3397-402.
 [http://dx.doi.org/10.1093/ndt/gfn291] [PMID:  18495742]

[59]
Drüeke TB. Klotho, FGF23, and FGF receptors in chronic kidney disease: A yin-yang situation? Kidney Int  2010; 78(11): 1057-60.
 [http://dx.doi.org/10.1038/ki.2010.339] [PMID:  21076444]

[60]
Kempe DS, Ackermann TF, Fischer SS, et al. Accelerated suicidal erythrocyte death in Klotho-deficient mice. Pflugers Arch  2009; 458(3): 503-12.
 [http://dx.doi.org/10.1007/s00424-009-0636-4] [PMID:  19184092]

[61]
Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol  2011; 22(1): 124-36.
 [http://dx.doi.org/10.1681/ASN.2009121311] [PMID:  21115613]

[62]
Lim K, Lu T-S, Molostvov G, et al. Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation  2012; 125(18): 2243-55.

[63]
Riancho JA, Valero C, Hernández JL, et al. Association of the F352V variant of the klotho gene with bone mineral density. 2007; 8(2): 121-7.
 [http://dx.doi.org/10.1007/s10522-006-9039-5]

[64]
Mirhosseini NZ, Shahar S, Ghayour-Mobarhan M, et al. Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents. J Bone Miner Metab  2013; 31(4): 468-76.
 [http://dx.doi.org/10.1007/s00774-013-0433-1] [PMID:  23475127]

[65]
Sultan S, Irfan SM, Ahmed SI. Biochemical markers of bone turnover in patients with β-thalassemia major: A single center study from southern Pakistan. Adv Hematol  2016; 2016: 5437609.
 [http://dx.doi.org/10.1155/2016/5437609] [PMID:  27006658]

[66]
Hu MC, Kuro-o M, Moe OW, Eds. Renal and extrarenal actions of klotho. Semin Nephrol 2013.

[67]
Hu MC, Kuro-o M, Moe OW. Secreted klotho and chronic
kidney disease. Endocrine FGFs and Klothos  2012; 126-57.
 [http://dx.doi.org/10.1007/978-1-4614-0887-1_9]

[68]
Hu MC, Kuro-o M, Moe OW. The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant  2012; 27(7): 2650-7.
 [http://dx.doi.org/10.1093/ndt/gfs160] [PMID:  22802580]

[69]
Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Bone  2017; 100: 87-93.
 [http://dx.doi.org/10.1016/j.bone.2016.11.012] [PMID:  27847254]

[70]
Salanova Villanueva L, Sánchez González C, Sánchez Tomero JA, Aguilera A, Ortega Junco E. Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications. Nefrologia  2016; 36(4): 368-75.
 [http://dx.doi.org/10.1016/j.nefro.2016.01.011] [PMID:  27118192]

[71]
Kuro-O M. The FGF23 and Klotho system beyond mineral metabolism. Clin Exp Nephrol  2017; 21(1) (Suppl. 1): 64-9.
 [http://dx.doi.org/10.1007/s10157-016-1357-6] [PMID:  27838783]

[72]
Takenaka T, Inoue T, Miyazaki T, Hayashi M, Suzuki H. Xeno‐klotho inhibits parathyroid hormone signaling. J Bone Miner Res  2016; 31(2): 455-62.
 [http://dx.doi.org/10.1002/jbmr.2691] [PMID:  26287968]

[73]
Pirinççioğlu AG, Gökalp D, Söker M. arathyroid functions in
thalassemia major patients. Ann Clin Endocrinol Metab  2017; 1: 015-9.

[74]
David V, Martin A, Isakova T, et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int  2016; 89(1): 135-46.
 [http://dx.doi.org/10.1038/ki.2015.290] [PMID:  26535997]

[75]
Tharwat RJ, Balilah S, Habib HM, et al. Ferritin and vitamin D levels and its relation to bone diseases in thalassemic adults: A hospital-based retrospective cohort study. J Appl Hematol  2019; 10(1): 15.
 [http://dx.doi.org/10.4103/joah.joah_56_18]

[76]
Forster RE, Jurutka PW, Hsieh JC, et al. Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun  2011; 414(3): 557-62.
 [http://dx.doi.org/10.1016/j.bbrc.2011.09.117] [PMID:  21982773]

[77]
Lips P. Vitamin D physiology. Prog Biophys Mol Biol  2006; 92(1): 4-8.
 [http://dx.doi.org/10.1016/j.pbiomolbio.2006.02.016] [PMID:  16563471]

[78]
Kuro-o M. Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol  2013; 9(11): 650-60.
 [http://dx.doi.org/10.1038/nrneph.2013.111] [PMID:  23774819]

[79]
Alesutan I, Feger M, Pakladok T, et al. 25-Hydroxyvitamin D3 1-α-hydroxylase-dependent stimulation of renal klotho expression by spironolactone. Kidney Blood Press Res  2013; 37(4-5): 475-87.
 [http://dx.doi.org/10.1159/000355728] [PMID:  24247665]

[80]
Bian A, Xing C, Hu MC. Alpha Klotho and phosphate homeostasis. J Endocrinol Invest  2014; 37(11): 1121-6.
 [http://dx.doi.org/10.1007/s40618-014-0158-6] [PMID:  25194425]

[81]
Cheddani L, Leblanc T, Silve C, et al. Iron chelation resulting in renal phosphate wasting. Kidney Int Rep  2017; 3(1): 1-4.
 [http://dx.doi.org/10.1016/j.ekir.2017.07.011] [PMID:  29340306]

Rights & Permissions Print Cite

Article Metrics

42

2

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1566524022666220607163232	Print ISSN 1566-5240
Publisher Name Bentham Science Publisher	Online ISSN 1875-5666

Current Molecular Medicine

In Transfusion-Dependent Thalassemia Children, Increased Iron Overload is Associated with Lower Serum Alpha-Klotho, Which is Strongly Associated with Lower Total and Ionized Calcium Concentrations

Abstract

Related Journals

Related Books

Related Articles